US Stock MarketDetailed Quotes

IVVD Invivyd

Watchlist
  • 2.350
  • -0.130-5.24%
Close Apr 18 16:00 ET
280.17MMarket Cap-1298P/E (TTM)

About Invivyd Company

Invivyd, Inc.(formerly Adagio Therapeutics, Inc.) engages in the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The firm develops antibodies that can neutralize SARS-CoV-2, SARS-CoV-1, and additional emergent coronaviruses. It offers, ADG20, a monoclonal antibody targeting the spike protein of SARS-CoV-2 and related coronaviruses. The company was founded by Tillman U. Gerngross, Ren Russo and Laura Walker on June 3, 2020 and is headquartered in Waltham, MA.

Company Profile

SymbolIVVD
Company NameInvivyd
Listing DateAug 6, 2021
Founded2020
CEOMr. Jeremy Gowler
MarketNASDAQ
Employees95
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address1601 Trapelo Road,Suite 178
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02451
Phone1-781-819-0080
Websitehttp://www.adagiotx.com

Company Executives

  • Name
  • Position
  • Salary
  • Jeremy Gowler
  • Chief Operating Officer, Chief Commercial Officer and Interim Chief Executive Officer
  • --
  • Jill Andersen
  • Chief Legal Officer and Corporate Secretary
  • 3.86M
  • William Duke
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Stacy Price
  • Chief Technology and Manufacturing Officer
  • --
  • Peter Schmidt
  • Chief Medical Officer
  • --
  • Marc Elia
  • Chairman of the Board
  • 352.99K
  • Dr. Clive A. Meanwell, M.D.,PhD
  • Director
  • 336.78K
  • Sara Cotter
  • Director
  • --
  • Tan Berry
  • Director
  • 334.50K
  • Michael Stephen Wyzga
  • Independent Director
  • 225.09K
  • Terrance G. Mcguire
  • Independent Director
  • 201.22K
  • Christine Lindenboom
  • Independent Director
  • 356.54K
  • Tomas J. Heyman
  • Independent Director
  • 220.36K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg